P ost-antifungal effect (PAFE) of Candida and its production of hemolysin are determinants of candidal pathogenicity. Candida albicans is the foremost aetiological agent of oral candidosis, which can be treated with polyene, azole, and echinocandin antifungals. However, once administered, the intraoral concentrations of these drugs tend to be subtherapeutic and transient due to the diluent effect of saliva and cleansing effect of the oral musculature. Hence, intra-orally, Candida may undergo a brief exposure to antifungal drugs. Objective: Therefore, the PAFE and hemolysin production of oral C. albicans isolates following brief exposure to sublethal concentrations of the foregoing antifungals were evaluated. Material and Methods: A total of 50 C. albicans oral isolates obtained from smokers, diabetics, asthmatics using steroid inhalers, partial denture wearers and healthy individuals were exposed to sublethal concentrations of nystatin, amphotericin B, caspofungin, ketoconazole DQG ÀXFRQD]ROH IRU PLQ 7KHUHDIWHU WKH GUXJV ZHUH UHPRYHG DQG WKH 3$)( DQG KHPRO\VLQ production were determined by previously described turbidometric and plate assays, respectively. Results: Nystatin, amphotericin B, caspofungin and ketoconazole induced mean PAFE (hours) of 2.2, 2.18, 2.2 and 0.62, respectively. Fluconazole failed to produce a PAFE. Hemolysin production of these isolates was suppressed with a percentage reduction of 12.27, 13.47, 13.33, 8.53 and 4.93 following exposure to nystatin, amphotericin B, FDVSRIXQJLQ NHWRFRQD]ROH DQG ÀXFRQD]ROH UHVSHFWLYHO\ &RQFOXVLRQV %ULHI H[SRVXUH to sublethal concentrations of antifungal drugs appears to exert an antifungal effect by interfering with the growth as well as hemolysin production of C. albicans.
INTRODUCTION
Multiple physiognomies of Candida species have been suggested as virulence factors that enable the organism to cause superficial as well as disseminated infections in susceptible hosts 11 . Hemolysins are known to be critical virulent determinants contributing to candidal pathogenesis 12 . In particular, the secretion of hemolysin, followed by lysis of erythrocytes and subsequent acquisition of iron by Candida, facilitates hyphal invasion that contributes to the recalcitrance of the disease 12, 13 . In Candida albicans, it has been shown that secretion of hemolytic factors causes the release of hemoglobin, which is then used as an iron source by the organism 13 . Others have proposed that hemoglobin is an important host factor that triggers a different metabolic pathway necessary for establishing disseminated infections by C. albicans 14 . For instance, adding hemoglobin WR GH¿QHG PHGLD IDFLOLWDWHV ELQGLQJ DQG DGKHVLRQ of the yeast to several host proteins. This activity of hemoglobin is independent of iron acquisition, and is facilitated by a cell surface hemoglobin receptor. Furthermore, hemoglobin rapidly induces the expression of several genes, one of which, a heme oxygenase, allows the pathogen to consume exogenous heme or hemoglobin to acquire iron and produce the cytoprotective molecules 14 . Such exquisite recognition and responses to hemoglobin appear to be a unique adaptation of C. albicans to be a versatile opportunistic pathogen in the human host 14 . C. albicans is by far the leading fungal pathogen of oral candidosis, the commonest human fungal infection with a variety of clinical manifestations 9 . Interestingly, more than 90% RI KXPDQ LPPXQRGH¿FLHQF\ YLUXV +,9 LQIHFWHG individuals develop oral candidosis during some point of their disease which is arguably the commonest oral manifestation in such patients. In addition, C. albicans has also been implicated in oral candidosis in other patient groups such as diabetics, asthmatics using inhalation steroids, smokers and denture wearers 10, 16, 17 . Recent studies have also shown that C. albicans isolates from subgingival biofilms of immunocompromised patients also produce hemolysins which may also exacerbate periodontal disease in these patients by insidiously HQKDQFLQJ WKH LQÀDPPDWRU\ SURFHVV DQG WLVVXH destruction 15 . Growth suppression of Candida that occurs subsequent to limited exposure to antifungal agents, as in the case of the oral environment, has been described as the post-antifungal effect (PAFE). It has been proposed that the knowledge of PAFE would be clinically useful in evaluating new dosage regimens of a drug, and such curtailment of growth following transient exposure to antifungal agents may be a determinant of candidal virulence itself, as this phenomenon may modulate the virulent attributes of the yeast Candida . Despite the availability of these pharmacological agents for the management of oral candidosis, failure of therapy and ensuing recalcitrant infection is not uncommon 9 . One reason for this may be the distinctive nature of the oral milieu where the diluent effect of saliva and the cleansing effect of the oral musculature tend to reduce the bioavailability of antifungal agents below that of the effective therapeutic concentrations. Hence, intra-orally, the pathogenic Candida may undergo a transient exposure to an antifungal agent on administration, and subsequently the drug concentration is likely to be subtherapeutic 5, 9 . Yet, the impact of such therapeutic levels of antifungals leading to PAFE and hemolysin production of oral C. albicans isolates obtained from different susceptible patient groups to oral candidosis (i.e., diabetics, asthmatics using inhalation steroids, smokers and partial denture wearers) has not been studied hitherto.
Hence, the main aim of this study was to determine the PAFE induced by five different antifungal agents belonging to three distinct classes, polyenes (nystatin, amphotericin B), echinocandins (caspofungin), and azoles (ketoconazole and ÀXFRQD]ROH RQ RUDO C. albicans isolates. The opportunity was also taken to evaluate candidal hemolysin production under identical conditions of drug exposure.
MATERIAL AND METHODS

Organisms
A total of 50 oral isolates of C. albicans obtained in a previous study from patients seeking treatment from the Kuwait University Dental Clinic were included in the current study (10 isolates each from smokers, diabetics, asthmatics using steroid inhalation, patients wearing partial acrylic dentures and healthy individuals) 7 . None of the patients from which the isolates were recovered had clinically visible oral candidosis. Initially, all Candida isolates were tested for germ tube formation. Thereafter the colony characteristics were observed using CHROMagar Candida medium (Becton Dickinson and &RPSDQ\ 6SDUNV 86$ DQG LGHQWL¿HG E\ 9,7(. yeast ID system (BioMérieux, France) as well as API 20C AUX yeast ID system (BioMérieux, Inc, Hazelwood, MO, USA).
Antifungal agents and media
Nystatin, amphotericin B, ketoconazole and fluconazole (Sigma, St. Louis, MO, USA) were dissolved in dimethylsulphoxide (DMSO). Caspofungin (Merck and Company Inc, Waterhouse Station, NJ, USA) was dissolved in sterile distilled water. These anti-Candida agents were prepared LQLWLDOO\ DV JPO DQG VWRUHG DW & SULRU to each experiment as previously described 4, 5 . It was thereafter suspended/diluted in the following medium during the exposure period of yeasts: RPMI (Roswell Park Memorial Institute) 1640 medium buffered with 0.165 M MOPS (3-(N-morpholino) propanesulfonic acid) containing L-glutamine and lacking sodium bicarbonate (Sigma, USA), dissolved in 1 liter of sterile distilled water and adjusted to a S+ RI DQG VWHULOL]HG ¿OWHU
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Preparation of cell suspension for the PAFE and hemolysin production assay
A heretofore explained method was used for this purpose [4] [5] [6] %ULHÀ\ Candida cells maintained on Sabouraud Dextrose Agar (SDA), were inoculated onto fresh plates and incubated overnight at 37°C for 24 h prior to use. The organisms were harvested and a cell suspension prepared in sterile phosphate buffered saline (PBS) at 520 nm to an optical density of 1.5. From this cell suspension, 1 ml was added to tubes containing 4 ml of RPMI broth (control) and 4 ml of RPMI/drug solution (test), in which the drug concentration was twice the MIC. This gave a cell suspension of approximately 10 6 cells ml -1 in each assay tube. The tubes were then incubated at 37°C for a period of 60 min. Following this limited exposure, the drugs were removed by two cycles of dilution with sterile PBS and centrifugation. Supernatant was thereafter completely decanted and the pellets were re-suspended in 2.5 ml of sterile PBS. This technique has been used previously for drug removal, and has revealed to minimize the concentration of the drug as much as 10,000 fold, thus curtailing any carry-over effect of the drug following its removal [3] [4] [5] . Viable counts of the control and the test were performed after drug removal. As the procedure of drug removal effectively eliminated any carry-over effect, there was virtually no difference on the viable counts of the control and the tests following exposure to already diluted subtherapeutic concentrations of the drug, as observed in previous studies [4] [5] [6] .
PAFE assay
Following drug removal, in order to ascertain the growth suppression and ensue the recovery of fungal growth, namely the PAFE, the growth was determined by a previously described optical density method with minor amendments using the equation PAFE=T-C [4] [5] [6] . T is the time required for optical density of the drug-exposed cell suspension to reach the selected relative optical density of 0.05 value at 520 nm. C is the time required for optical density of the drug-free control cell suspension to reach the selected relative optical density value at 520 nm. Thus, T-C expresses the time in which the antifungal agent was capable of causing growth suppression of the organism following limited exposure to the drug (i.e., PAFE). As in previous VWXGLHV O RI FHOO VXVSHQVLRQ ZDV LQFXEDWHG with 2.4 mL of RPMI 1640 at 37°C and the relative optical density of the suspension was measured at frequent intervals (i.e., 15 min) for 8 h by which time, both the controls and tests reached the selected relative optical density value, enabling to calculate the PAFE [4] [5] [6] .
Hemolysin assay
Hemolysin production was determined with VOLJKW PRGL¿FDWLRQV XVLQJ D SODWH DVVD\ SUHYLRXVO\ described 1, 12, 13 ,Q VKRUW O RI WKH DIRUHPHQWLRQHG treated antifungal and control suspensions were spot-inoculated on a blood agar supplemented with JOXFRVH ZY 7KH ¿QDO S+ RI WKH PHGLXP ZDV 5.6±0.2. Spot-inoculation was performed to yield a The plates were then incubated at 37°C in 5% CO 2 for 48 h. After incubation during this period, the diameter of the colony (y) and the diameter of the colony plus the translucent zone of hemolysis (x) were measured. The ratio of x/y, which represents the hemolytic activity (hemolytic index), was measured as done previously 1, 12, 13 . All experiments were repeated on three separate occasions with duplicate determinations on each occasion.
Statistical analysis
For the suppression effect on hemolysin production, the raw data did not follow normal distribution. ÀXFRQD]ROH +RZHYHU WKH 3$)( DQG WKH VXSSUHVVLYH effect on hemolysin production elicited by the two polyenes and the echinocandin agent were not VLJQL¿FDQWO\ GLIIHUHQW IURP HDFK RWKHU Finally, when comparing the clinical isolates from diabetics, asthmatics, smokers, denture wearers and healthy individuals, there were no difference in either PAFE or hemolysin production on exposure to sublethal concentrations of any of the antifungals.
DISCUSSION
C. albicans is by far the major aetiological agent of oral candidosis 8 . Hemolysin is one of C. albicans recently recognized, putative virulent factors. In particular, the secretion of hemolysin facilitates hyphal invasion, which is critical for disseminated candidal infection 1,12-14 . As described above, it is known that PAFE, the capacity of Candida to recover and grow after an antifungal-insult, is another important measure of the virulence of the yeast [4] [5] [6] [7] . We, along with others, have shown that more 4, 9 . Considering the foregoing wide range pharmacodynamic properties of the agents we have studied, it is tempting to speculate that the structural changes of the cell wall, as well as the metabolic effects elicited by the drugs, would all contribute to the suppression of growth eliciting D 3$)( 6XUSULVLQJO\ ÀXFRQD]ROH IDLOHG WR HOLFLW a detectable PAFE response in spite of this drug being remarkably more effective in vivo than ketoconazole in the management of candidal infection 9 . Interestingly, many workers have shown WKDW ÀXFRQD]ROH ¶V JURZWK LQKLELWRU\ DFWLYLW\ DJDLQVW C. albicans isolates in vitro is much less than that of ketoconazole 4, 9, 18 . Hence, the later could be one reason for the absence of detectable PAFE following
The exposure of C. albicans isolates to the foregoing drugs was also capable of suppressing KHPRO\VLQ SURGXFWLRQ RI WKH \HDVW WR VLJQL¿FDQW varying levels ranging from 5% to 13.5%. A previous single study has also shown a reduction of hemolysin activity of C. albicans, as well as Candida tropicalis isolates, following exposure to Q\VWDWLQ DPSKRWHULFLQ % DQG ÀXFRQD]ROH 1 . It is UDWKHU GLI¿FXOW WR IDWKRP WKH H[DFW PHFKDQLVP E\ which these drugs modulate changes in hemolysin production in Candida species. However, taken collectively, WKH FXUUHQW ¿QGLQJV FRQWULEXWH WR WKH understanding of pharmacodynamics of these antifungal agents against two virulent determinants (i.e., PAFE and hemolysin production) incriminated in the pathogenesis of C. albicans infections. In addition, as hemolysins are known to mediate host invasion, particularly by facilitating hyphal penetration of the epithelium, it can be speculated that, by suppressing hemolysin production, these antifungals could also minimize yeast dissemination from and within the oral and periodontal tissues.
7KH VLJQL¿FDQW GLIIHUHQFH LQ 3$)( HOLFLWHG E\ polyenes and echinocandins and azoles, as well as their suppressive effect on hemolysin production of Candida, as seen in this study, may well be due to the differences in the pharmacodynamics of the different antimycotic groups. Polyenes and echinocandins are fungicidal against C. albicans whereas azoles are fungistatic 9 . This could be the foremost explanation for the exquisite sensitivity of C. albicans to nystatin, amphotericin B and caspofungin compared to the azoles. In addition, we also noted a significant difference in the PAFE and hemolysin production when the yeasts were exposed to the two azoles. As previously mentioned, others have shown that the growth LQKLELWRU\ DFWLYLW\ RI ÀXFRQD]ROH DJDLQVW C. albicans in vitro is much less than that of ketoconazole 4, 9, 18 . These observations may be related to the fact that NHWRFRQD]ROH LV DQ LPLGD]ROH ZKHUHDV ÀXFRQD]ROH is a triazole. Arguably, therefore, the differences in the mode of activity between the two azoles may DFFRXQW IRU NHWRFRQD]ROH DQG ÀXFRQD]ROH HOLFLWHG variations in PAFE and hemolysin production.
7R RXU NQRZOHGJH WKH FXUUHQW VWXG\ LV WKH ¿UVW one to document the antifungal-induced PAFE using a wide array of antifungal agents and the suppression of hemolysin production during the PAFE period, covering the largest number (n=50) of oral C. albicans isolates obtained from a single geographic locale. Testing with a larger number of sessile isolates encased in a Candida ELR¿OP scenario instead of using only planktonic isolates as used in this study is warranted to further elucidate WKH FXUUHQW ¿QGLQJV The exact cellular mechanisms by which antifungals interfere with hemolysin activity in Candida also remain to be elucidated.
CONCLUSIONS
Brief and transient exposure to sublethal concentrations of antifungal drugs may induce a PAFE and modulate hemolysin production of oral C. albicans isolates, thereby adversely affecting their pathogenic potency. The data herein also provide an insight into the possible mechanisms of antifungal agents, at subtherapeutic concentrations, in biological milieus such as the oral cavity.
